1 perate South Atlantic using an original flow
cytometric (
14)CO2-tracer approach.
2 Immunofluorescent staining and flow
cytometric analyses characterized CLIO-NPs, MPO, endothe
3 Immunohistochemical and flow
cytometric analyses demonstrated that prednisolone treat
4 Moreover, flow
cytometric analyses for B-cell markers revealed an MDM2-
5 Flow
cytometric analyses further confirmed that over-expressi
6 Our multicolor flow
cytometric analyses of human decidual leukocytes detecte
7 Virtually digested" WSI enabled quantitative
cytometric analyses of individual cells displayed in a v
8 Notably, flow
cytometric analyses of lung CD8(+) T cells revealed a sh
9 zed by immunohistochemistry, along with flow
cytometric analyses of lymphocytes for iNOS expression a
10 AFIA versus clodronate-treated mice and flow
cytometric analyses of myeloid lineage cells in the bone
11 Flow
cytometric analyses on dendritic cells (DCs) in vitro an
12 Cell numbers were adequate to perform flow
cytometric analyses on T cell lineage, T cell activation
13 Finally, flow
cytometric analyses revealed that IL-15 increases the pr
14 Flow
cytometric analyses showed significant accumulation of M
15 Flow
cytometric analyses showed that the susceptibility of EC
16 Flow
cytometric analyses were used to follow responses in the
17 evaluated with imaging, histology, and flow
cytometric analyses, together with wild-type controls.
18 at various times after immunization for flow
cytometric analyses.
19 the traditional sample-by-sample approach in
cytometric analysis and highlight the need for scalable
20 7-H4 protein expression was examined by flow
cytometric analysis and immunohistochemical staining.
21 and cytokine profiles were assessed by flow
cytometric analysis and multiplex assay.
22 Flow-
cytometric analysis and quantitative real-time polymeras
23 ddress this, we combined multiparameter flow
cytometric analysis and T-cell subpopulation sorting wit
24 Flow
cytometric analysis and Western blots showed that blocki
25 By flow
cytometric analysis at early times during infection, nei
26 Flow
cytometric analysis confirmed that the aggravated tissue
27 Flow
cytometric analysis demonstrated an expanded CD19+ CD5+
28 an intracellular cytokine staining and flow
cytometric analysis detecting four functional markers si
29 Flow
cytometric analysis found elevated renin content in prin
30 Flow
cytometric analysis indicated GPR18 deficiency more stro
31 as evidenced by a mammosphere assay and flow
cytometric analysis of aldehyde dehydrogenase 1 (ALDH1)
32 Flow
cytometric analysis of basophil responses implied labeli
33 Flow
cytometric analysis of blood and fibroblasts from affect
34 Flow
cytometric analysis of blood cells and fibroblasts from
35 cted from subjects with chronic HCV for flow
cytometric analysis of CCR expression on CD8+ T cells.
36 ts with AAV and 19 healthy controls for flow
cytometric analysis of CD4+ T cell populations.
37 utational algorithms have been developed for
cytometric analysis of cells and proteins in subcellular
38 Flow
cytometric analysis of cells from rectal biopsy specimen
39 In our study, flow
cytometric analysis of circulating MDSCs from 20 gastric
40 Flow
cytometric analysis of CNS-infiltrating mononuclear cell
41 Ex vivo flow-
cytometric analysis of DENV-specific CD4(+) T cells reve
42 in lymphocytes were quantified through flow
cytometric analysis of H2AX phosphorylation (gamma-H2AX)
43 Fluidigm BioMark and multiparameter flow
cytometric analysis of HIV-specific cytolytic CD4+ T cel
44 Furthermore, flow
cytometric analysis of HSV-1-infected corneal cells duri
45 chain-reaction (qPCR) assay, as well as flow-
cytometric analysis of IgG antibody responses against tw
46 Flow
cytometric analysis of immune cell subsets was performed
47 ulmonary inflammation by histologic and flow
cytometric analysis of immune cells.
48 or vehicle, tumour load was measured by flow
cytometric analysis of infiltrated spleens, and subclona
49 Flow
cytometric analysis of ischemic muscles at day 2 reveale
50 Flow
cytometric analysis of lung tissue from H2 R-deficient a
51 Flow
cytometric analysis of microglial cells obtained from in
52 Flow
cytometric analysis of monoclonal anti-Bw4 antibody show
53 Mass
cytometric analysis of monocyte subsets and signaling pa
54 Flow
cytometric analysis of multiple organs, including the ki
55 Flow
cytometric analysis of mutant Lkt-treated PMNs revealed
56 rimental allergen challenge model, with flow
cytometric analysis of nasal curettage samples, to asses
57 Flow
cytometric analysis of NPs (n = 9) showed that 5.1% +/-
58 Flow
cytometric analysis of peripheral blood B cells of 30 MC
59 thy subjects were included for 11-color flow
cytometric analysis of peripheral blood for IgG4-express
60 Here, flow
cytometric analysis of peripheral blood mononuclear cell
61 nced pan-lymphopenia as demonstrated by flow
cytometric analysis of peripheral blood.
62 Flow-
cytometric analysis of primary human NK cells as well as
63 Using flow
cytometric analysis of resected adenomatous parathyroid
64 We used flow
cytometric analysis of sinonasal mucosal tissues of 29 C
65 Flow
cytometric analysis of splenocytes from infected mice re
66 Flow
cytometric analysis of SUSD3-knockdown cells revealed bl
67 Flow
cytometric analysis of synaptosome preparations was used
68 Flow
cytometric analysis of tetramer-reactive B cell subsets
69 Flow
cytometric analysis of the cell cycle demonstrated an in
70 Flow
cytometric analysis of the ocular infiltrate in WT mice
71 sments included body and organ weights, flow
cytometric analysis of thymocytes and splenocytes, and h
72 Flow
cytometric analysis of tumor-infiltrated macrophages sho
73 Flow
cytometric analysis on the collected samples found that
74 Flow
cytometric analysis revealed 3 distinct neutrophil popul
75 Flow
cytometric analysis revealed 97.9%+/-1.5% and 94.3%+/-5.
76 Flow
cytometric analysis revealed a significant increase in t
77 Flow
cytometric analysis revealed a significant reduction of
78 Flow-
cytometric analysis revealed increased numbers of regula
79 Flow
cytometric analysis revealed significant reduction of fr
80 omodulatory because gene expression and flow
cytometric analysis revealed significantly decreased imm
81 Flow
cytometric analysis revealed that 16E6, but not 6E6, sup
82 Flow
cytometric analysis revealed that a sizable sub-populati
83 Flow
cytometric analysis revealed that both species possess 2
84 Flow
cytometric analysis revealed that the percentage of PD-1
85 Flow
cytometric analysis showed a 41.7% increase in the mean
86 Flow
cytometric analysis showed aFP treatment elicited an inc
87 Flow
cytometric analysis showed alterations in tumor-infiltra
88 Flow
cytometric analysis showed impairment of erythroid diffe
89 Flow
cytometric analysis showed that CD1a(+) cells in NPs mig
90 Flow
cytometric analysis showed that the BF of CurDD shifted
91 is decreased plaque macrophage content, flow
cytometric analysis showed that the numbers of circulati
92 Edu-labelled flow
cytometric analysis showed that the percentage of the Ed
93 Flow
cytometric analysis showed the increase in IFN-gamma cor
94 Flow
cytometric analysis shows that both the location and act
95 Finally, a
cytometric analysis shows that the TREM1 rs6910730(G) al
96 B cell ELISpot and flow
cytometric analysis suggest that short-term fostamatinib
97 Flow
cytometric analysis suggested that Ifitm3(-/-) macrophag
98 Ex vivo flow
cytometric analysis supported a direct effect of myeloma
99 l in vitro affinity selections based on flow
cytometric analysis that allows fine quantitative discri
100 Here, through flow
cytometric analysis the small-molecule macrocycle cyclot
101 ssue explants and optimized a method of flow
cytometric analysis to directly quantify infection rates
102 h is in quantitative agreement with the flow
cytometric analysis using fluorescent labels.
103 pe of cell death or cell cycle arrest a flow
cytometric analysis was applied.
104 In addition, flow
cytometric analysis was performed to determine the impac
105 Flow
cytometric analysis was used to investigate the origin o
106 Flow
cytometric analysis was used to monitor immune cell freq
107 ntegrating whole-blood transcriptomics, flow-
cytometric analysis, and plasma cytokine and antibody pr
108 By using flow
cytometric analysis, enzyme and receptor inhibitors, and
109 as evidenced by immunohistochemical and flow
cytometric analysis.
110 (HSPCs) were decreased in NHD13 mice by flow
cytometric analysis.
111 ral blood mononuclear cell samples with flow
cytometric analysis.
112 ication of single platelet depletion by flow
cytometric analysis.
113 ammation) was measured via a bead-based flow
cytometric analysis.
114 mmunoblotting, immunocytochemistry, and flow
cytometric analysis.
115 e antigen-DR (HLA-DR), and subjected to flow
cytometric analysis.
116 e examined by 7-amino-actinomycin D and flow
cytometric analysis.
117 to type 1 alveolar epithelial cells by flow
cytometric analysis.
118 y reagents by yeast display followed by flow
cytometric analysis.
119 on therapy underwent a liver biopsy for flow
cytometric analysis.
120 ndirect immunofluorescence staining and flow-
cytometric analysis.
121 from NPs and matched blood samples for flow
cytometric analysis.
122 Both flow
cytometric and antibody-mediated neutralization studies
123 erted into (19)F nanoparticles to allow flow-
cytometric and confocal microscopy analysis of labeled c
124 With histological, flow
cytometric and functional analyses, we find that CPCs re
125 Flow
cytometric and gene expression analyses revealed that VA
126 Flow
cytometric and high-content imaging saturation and compe
127 Flow
cytometric and immunoblotting results suggest that CurDD
128 ha expression patterns were examined by flow
cytometric and immunofluorescence analysis.
129 tumour cells, which we corroborated by flow
cytometric and metabolomic analyses.
130 nly based on single-cell analysis as in flow
cytometric and microfluidic cell sorters.
131 Phagocytic uptake was detected using flow
cytometric and microscopic techniques.
132 In this study, we developed flow
cytometric and T cell enzyme-linked immunosorbent spot (
133 Through flow
cytometric and transcriptional analyses of lymphoid, muc
134 Herein we used detailed transcriptomic, flow
cytometric,
and functional analysis and transcription fa
135 s of lungs were assessed by histologic, flow
cytometric,
and quantitative PCR analysis.
136 Functional autoreactive, flow
cytometric,
and single-cell cloning assays have proven t
137 d 27 healthy subjects using an 11-color flow
cytometric antibody panel.
138 d 25 healthy subjects using an 11-color flow
cytometric antibody panel.
139 lines coupled with RNA interference and flow
cytometric approaches, we find that transforming growth
140 atabase for 49 Helianthus species using flow
cytometric approaches.
141 We have developed a flow
cytometric assay for inflammasome formation, time of fli
142 his study, we used a recently developed flow
cytometric assay for the direct ex vivo characterization
143 s volume (MCV) and reticulocytosis; the flow-
cytometric assay showed good correlation with the spectr
144 elease assay (IGRA) was combined with a flow
cytometric assay that detects induction of CD25(+)CD134(
145 Using a Click-iT flow
cytometric assay to directly measure mitotic protein syn
146 We applied a simplified flow
cytometric assay to identify patients with precursor B-c
147 We developed a flow
cytometric assay to profile CD1-restricted T cells ex vi
148 We developed a flow-
cytometric assay to study membrane protein-protein inter
149 A simple, high-throughput flow
cytometric assay was developed that uses THP-1 cells and
150 munosorbent assay and microsphere-based flow
cytometric assay were used to verify the levels of the c
151 he spectrophotomeric assay and the G6PD flow-
cytometric assay.
152 ctivation of leukocytes was assessed by flow
cytometric assays and by immunofluorescence microscopy.
153 We then used flow
cytometric assays capable of measuring total and Ag-spec
154 Flow
cytometric assays combined with intra-vital imaging indi
155 This was confirmed by
cytometric assays showing that inactive compounds failed
156 As judged from flow
cytometric assays, bacterial killing by GA occurred with
157 s is consistent with that of commercial flow
cytometric assays.
158 rful analytical technique for multiparameter
cytometric assays.
159 ested using the lymphoproliferation and flow
cytometric assays.
160 LISA, Luminex, quantitative RT-PCR, and flow
cytometric assays.
161 Flow
cytometric assessment and mathematical modeling of intra
162 ated in vitro with peanut allergens for flow
cytometric assessment of the percentage of CD63(hi) acti
163 ecay rapidly to pMHC monomers, allowing flow-
cytometric-
based measurements of monomeric TCR-pMHC diss
164 We developed a novel
cytometric bead array for assessment of antigen-specific
165 Additionally, cytokines were measured by
cytometric bead array, and L-ficolin was measured in bro
166 ee supernatants were quantified by using the
cytometric bead array, and mRNA expression of transcript
167 A
cytometric bead array, ELISA, and intracellular cytokine
168 rescein diacetate succinimidyl ester dye and
cytometric bead array, formed an in vitro surrogate mark
169 protein signatures were determined by ELISA,
cytometric bead array, or quantitative PCR.
170 in-6 and interleukin-10 concentrations using
cytometric bead array.
171 ll responses by enzyme-linked immunospot and
cytometric bead array.
172 on was assessed in supernatants by using the
Cytometric Bead Array.
173 evels of CCL11 were measured in plasma using
Cytometric Bead Array.
174 cytokines/chemokines were determined with a
cytometric bead array.
175 n with mitogenic, TLR, and T-cell stimuli by
cytometric bead array.
176 n malaria (IL-5 and RANTES) were assessed by
cytometric bead assay in April 2008, October 2008, and A
177 asmodium falciparum antigens was assessed by
cytometric bead assay or enzyme-linked immunosorbent ass
178 Here, using flow
cytometric,
biochemical, and immunofluorescence techniqu
179 Flow
cytometric,
bulk, and single-cell RNA-sequencing analyse
180 ly, we developed a rapid multiparameter flow
cytometric CBU potency assay that enumerates cells expre
181 Flow
cytometric cell cycle analysis of HUVECs treated with Ss
182 A combination of flow
cytometric cell sorting and deep sequencing of the 16S r
183 ecology was explored through combining flow
cytometric cell sorting and molecular techniques to dete
184 ere used for immunostaining in situ and flow
cytometric cell sorting.
185 Flow
cytometric characterization of Ag-specific T cells typic
186 Flow
cytometric characterization of expression of CD30 and ma
187 erapeutic options.METHODSWe performed a flow
cytometric characterization of immune cell subsets from
188 between 1980 and 2013 that include the flow
cytometric characterization of leukocyte subsets in the
189 n, we performed detailed functional and mass
cytometric cluster analysis of multiple CD8(+) T-cell cl
190 Flow
cytometric counts revealed that exposure of human macrop
191 p; 76.3% for recipients with a positive flow-
cytometric cross-match but a negative cytotoxic cross-ma
192 ay for anti-HLA antibody but a negative flow-
cytometric cross-match versus 65.0% for the waiting-list
193 ible and had a negative or low-positive flow
cytometric crossmatch (+XM).
194 reened for human antibody binding using flow
cytometric crossmatch (FCXM).
195 rossmatch (CDC-XM) and donor cell-based flow
cytometric crossmatch (flow-XM) but low level DSA (i.e.,
196 detected by single antigen beads and B flow
cytometric crossmatch (XM).
197 Pig reactivity was assessed by direct flow
cytometric crossmatch and studied following elution from
198 t in B4GALNT2 genes were examined using flow
cytometric crossmatch assay.
199 el was insufficient to cause a positive flow
cytometric crossmatch.
200 Flow
cytometric crossmatching (FXM) is a standard method to a
201 ), was developed and applied to analyze flow
cytometric data of bacterial responses to antibiotic exp
202 e 3-dimensional differences between the flow
cytometric data of the no-antibiotic treated bacteria an
203 The presentation of high-dimensional
cytometric data using One-SENSE showed a significant imp
204 uencing or after careful examination of flow
cytometric data, as in the reports of lymphocyte-specifi
205 nts and blind multicenter reanalysis of flow
cytometric data, resulting in an unprecedented concordan
206 ng the complexity and information content of
cytometric data.
207 nformation contained in a highly dimensional
cytometric dataset.
208 The FASD system uses
cytometric detection and electrohydrodynamic actuation-b
209 We used a stepwise approach for flow
cytometric detection and purification of human IgE-expre
210 These results and flow
cytometric detection of CD45 and CD127 suggest the prese
211 EBV-specific T cells were quantified by flow
cytometric detection of intracellular interferon-gamma a
212 we tested the diagnostic performance of flow-
cytometric detection of PKCepsilon expressing platelets
213 We demonstrate that flow
cytometric detection of poorly differentiated basal tumo
214 +/CD42b+ human megakaryocytes (MKs), to flow
cytometric detection of suspected anti-HPA-3 and HPA-9 a
215 rescein labeled folic acid was used for flow
cytometric detection of the expression of functional fol
216 rane assays amenable to high-throughput flow
cytometric detection.
217 Modern-era molecular and flow-
cytometric diagnostic methods are very sensitive and can
218 -throughput screening platform based on flow
cytometric droplet sorting (FCDS).
219 F, AMD3100 or ischemia was evaluated by flow
cytometric enumeration of circulating Lin(-)Sca-1(+)cKit
220 were harvested at these time points for flow
cytometric evaluation of immune cell subtypes and immuno
221 , therapeutic antibodies may complicate flow
cytometric evaluation of normal and neoplastic plasma ce
222 re normal or only slightly reduced, and flow
cytometric evaluations of the TCR-Vbeta repertoires of t
223 We report the flow
cytometric (
FC) identification and characterization of l
224 Consistent with flow
cytometric findings, microscopic imaging supported an im
225 We used flow
cytometric (
fluorescence-activated cell sorting) analysi
226 We identified by flow
cytometric,
fluorescent microscopic, immunoblot, and mas
227 Here we sought to develop a flow
cytometric gating strategy to reliably identify blood Ig
228 Myeloid cells were characterized in flow
cytometric,
histologic, and immunohistochemical analyses
229 describe a fluorescence-based multiplex flow-
cytometric host cell reactivation assay (FM-HCR) that me
230 Using a fluorescence-based multiplex flow
cytometric host cell reactivation assay that provides si
231 eveloped a fluorescence-based multiplex flow-
cytometric host cell reactivation assay wherein the acti
232 We describe a protocol for flow
cytometric identification of viral reservoirs, based on
233 Multiplexed, phenotypic, intravital
cytometric imaging requires novel fluorophore conjugates
234 servations were more deeply analyzed by flow
cytometric imaging, confocal imaging, and measurement of
235 T cells were purified and subjected to flow
cytometric immune-phenotyping and functional assays.
236 ate protein-DNA binding is monitored by flow
cytometric immunofluorescence, which allows for accurate
237 proliferative, we applied comprehensive flow
cytometric immunophenotyping and functional assays of cy
238 To date, flow
cytometric immunophenotyping has not been used to invest
239 CD45 barcoding facilitates accuracy of mass
cytometric immunophenotyping studies, thus supporting bi
240 ined single-cell functional assays with flow
cytometric index sorting and single-cell gene expression
241 In this article, we report a flow
cytometric investigation of B lymphocyte subpopulations
242 tive isolation, complex multi-parameter flow
cytometric isolation of phenotypic subsets has facilitat
243 In conclusion, flow
cytometric LPT represents a reliable and useful method f
244 We established a flow
cytometric lymphocyte proliferation test (LPT) for the d
245 ompartment constructed from single-cell mass
cytometric measurements of 14 cell surface markers, 20 s
246 Flow
cytometric measurements revealed that Si (50 mug/ml) sig
247 Flow
cytometric membrane integrity staining demonstrated the
248 the infected host, we developed a novel flow
cytometric method for measuring lysosome damage.
249 In this study we present a flow
cytometric method identifying HBEC as CD45 negative, EpC
250 we describe a 2-d, 96-well plate-based flow
cytometric method of micronucleus scoring that is simple
251 Vs, we used nanoFACS, a high-resolution flow
cytometric method that utilizes light scattering and flu
252 ave developed, validated, and applied a flow
cytometric method that will be useful to interrogate the
253 To date, a flow
cytometric method to identify HBEC recovered from lower
254 The current flow
cytometric method, time of flight inflammasome evaluatio
255 Emerging high-resolution
cytometric methods have created a pressing need for effi
256 Cytometric methods revealed extensive neutrophilic infil
257 Cytometric monitoring of microbial community dynamics ca
258 We compared the BM flow
cytometric,
morphologic, and cytogenetic features of 28
259 In this report, we describe a mass
cytometric,
multidimensional, individual cell analysis o
260 Here we established an assay based on flow
cytometric multiparameter assay assessing expression of
261 D38 core gating systems and an 11-color flow
cytometric panel were used to determine the frequencies
262 PSFC the fluorescence lifetime is taken as a
cytometric parameter to differentiate intracellular even
263 the flexibility of employing a wide range of
cytometric parameters for identifying colonies and cells
264 differences between sample and control flow
cytometric populations, even in a label-free scheme with
265 table after treatment, correlating with flow
cytometric presence or absence of circulating M-PCs.
266 at prostate cancer can be identified by flow
cytometric profiling of blood immune cell subsets.
267 ent cell barcoding with high-throughput flow
cytometric profiling of primary and metastatic colon can
268 Here we show, using transcriptional and
cytometric profiling of whole blood collected before vac
269 ografting, and multiplexed phospho-flow (PF)
cytometric profiling to study drug response and identify
270 ngle-cell genomic, transcriptional, and mass-
cytometric profiling, it remains a challenge to collect
271 erived microparticles by a standardized flow
cytometric protocol in 119 patients referred for stress
272 +) regulatory T cells were subjected to flow
cytometric quantification and sorting followed by qRT-PC
273 y of human cells to HAP was examined by flow
cytometric quantification of apoptotic cell death and de
274 Phosphoflow
cytometric quantification of p70S6K phosphorylation may
275 ce resonance energy transfer (FRET) and flow
cytometric quantification.
276 s in adhesion receptor expression using flow
cytometric quantitation of integrins and l-selectin memb
277 expressing P. falciparum antigens and a flow
cytometric readout of infection, we are able to robustly
278 uorescent probes were investigated in a flow
cytometric screen of ABC transporters.
279 ss-reactive peptide ligand for a duplex flow
cytometric screen of FPR1 and FPR2 in color-coded cell l
280 of-principle study, we used comparative flow
cytometric screening to identify ICAM-1 as a potential t
281 elt (2800-6150 m) in NW Himalayas using flow
cytometric seed screen.
282 ture T cells, and VAMP-7 recapitulates light-
cytometric side scatter.
283 ere phenotyped and isolated by means of flow
cytometric sorting from 18 patients at baseline and 13 p
284 We show that flow
cytometric sorting of single cells effectively distingui
285 rmal and fibrotic livers via subsequent flow
cytometric sorting, thus providing a validated method to
286 ls purified by either bead selection or flow
cytometric sorting.
287 ed protocol that eliminated the need of flow
cytometric sorting.
288 Using both coimmunoprecipitation and flow-
cytometric strategies, we found a bidentate interaction
289 Here, we developed a flow-
cytometric strategy capable of detecting membrane protei
290 We implemented a flow
cytometric strategy to detect clonal Sezary cells based
291 Flow
cytometric studies using monoclonal antibodies show that
292 Cytometric studies utilizing flow cytometry or multi-wel
293 ge segmentation, provides a means to conduct
cytometric studies while at the same time preserving cru
294 confirmed in structural, serologic, and flow-
cytometric studies.
295 This in vivo
cytometric technique may be useful in a wide range of st
296 sease (MRD) by molecular genetic and/or flow
cytometric techniques.
297 chniques, including novel molecular and flow
cytometric technologies used for the determination of mi
298 Recent advances in
cytometric technology enable us to measure the abundance
299 This expanded menu of flow
cytometric testing approaches has increased the utility
300 o tracer biodistribution and to perform flow
cytometric,
Western blot, and immunohistochemical tumor